GSK2330672
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for GSK2330672, covering 2016-11-09 to 2021-05-04. Get the full timeline:
Most recent: Clinical Trial Update: Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis [Phase 2]